Omdia: LED Video Display Market Grows Steadily in 1Q25, Driven by Micro-LED Adoption and Fine Pixel Pitch Demand
'The first quarter of 2025 confirmed that the LED video display market is evolving beyond traditional applications,' said Cindy Liu , Senior Analyst at Omdia. 'With advances in pixel pitch technology and micro-LED, adoption is widening across multiple industries.'
Micro-LED, and mini-LED technologies continued gaining traction supported by progress in LED packaging, driver ICs and coating materials. These innovations improve brightness, energy efficiency, lifespan, HDR capabilities, and color accuracy – positioning LED displays as the premium option for cinema, retail, broadcast and control room applications.
'Vendors are responding to demand for seamless and flexible LED solutions in events, exhibitions and architectural displays. For example, Unilumin's UMicro series now offers 0.4mm, 0.6mm, 0.7mm and 0.9mm pixel pitches using flip chip and ink with coating technologies to boost grayscale consistency and thermal performance,' explained Liu.
Fine pixel pitch (FPP) displays dominated revenues in Q1 2025, increasing by 8.1% YoY, accounting for 55.4% of the market. The 1.50–1.99mm pixel pitch category was 11.1% YoY, driven by demand for all in one (AIO) corporate, conference room displays and outdoor poster displays. These offer a balance between resolution and brightness enabling new opportunities in retail, transportation, shelter and residential area scenarios.
As costs and thermal management challenges remain, FPP and micro-LED are expected to penetrate outdoor applications, including digital out-of-home (DOOH) advertising.
This momentum is particularly visible across emerging markets. In Asia & Oceania, as well as Latin America & the Caribbean and Middle East & Africa, growth is being powered by urbanization, digital advertising expansion, smart city initiatives, and large-scale public events.
In Q1 2025, Asia & Oceania recorded the highest revenue share in the FPP segment - 15.6% trailing only China and North America. In the 1.50–1.99mm pixel pitch, the region led globally with a 20.2% share surpassing North America. Government-driven smart city and infrastructure programs in India, Indonesia and Singapore are lifting demand in transportation, control room, public space and corporate verticals. Retailers are also rapidly adopting LED video displays for indoor and outdoor advertising.
In the Middle East & Africa, momentum from mega events like the 2022 FIFA World Cup continues to benefit the market. High-end retail and hospitality in cities like Dubai and Doha have adopted FPP LED video displays for branding. Regional governments are also investing in smart city initiatives such as Saudi Arabia's Vision 2030 and the UAE's Smart Dubai which are accelerating demand for public space installations.
In Latin America, the forecast remains strong due to rising DOOH advertising, upgrades in sports venues and growth in the retail and banking sectors. Preparations for Copa America and the 2030 World Cup are driving demand for LED video displays in stadiums, retail, transportation and public space verticals.
Omdia continues to monitor LED video display market developments across regions and technologies, providing in-depth insights through its LED Video Displays Market Tracker.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
24 minutes ago
- Associated Press
PureTech Announces Board Change
BOSTON--(BUSINESS WIRE)--Jul 8, 2025-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces that Raju Kucherlapati, PhD, has stepped down from his role as a member and Chair of the Board of Directors. 'Raju has been an integral part of PureTech's journey for almost two decades, and we are deeply grateful for his dedication and leadership,' said Bharatt Chowrira, PhD, JD, PureTech's Chief Executive Officer. 'On behalf of the board, I'd like to wish Raju all the best in his future endeavors.' PureTech has appointed Sharon Barber-Lui, PureTech's Audit Committee Chair, as Interim Chair of the Board of Directors. In collaboration with the Nominating Committee, Ms. Barber-Lui will lead the process to identify a new Chair of the Board of Directors and will engage with shareholders to gather input on the criteria and overall board evolution as part of the process. Robert Langer, ScD, PureTech's Co-founder and member of the board said, 'Raju is a unique individual, an amazing scientist, and a great friend and mentor to so many people in the biotech industry. It has been an honor and a privilege to serve alongside Raju for so many years at PureTech. I speak for the entire board in thanking him for his many years of dedication and his outstanding contributions.' During his tenure on the board, Dr. Kucherlapati helped guide PureTech from its startup phase into an established biotherapeutics company, which has an industry-leading track record of advancing breakthrough medicines, such as the recently FDA-approved Cobenfy™, and launching innovative Founded Entities, most recently, Seaport Therapeutics. About PureTech Health PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep portfolio through its experienced research and development team and its extensive network of scientists, clinicians, and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including three that have been approved by the U.S. Food and Drug Administration. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration-enabling studies. All of the underlying programs and platforms that resulted in this portfolio of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points. For more information, visit or connect with us on X (formerly Twitter) @puretechh. Cautionary Note Regarding Forward-Looking Statements This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements that relate to our expectations around our therapeutic candidates and approach towards addressing major diseases, our intention to initiate a process to identify a new Chair of the Board of Directors, our future prospects, developments, and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption 'Risk Factors' in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC and in our other regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, we disclaim any obligation to update or revise these forward-looking statements, whether as a result of new information, future events or source version on CONTACT: PureTech Investor Relations [email protected] KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA MASSACHUSETTS INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH OTHER HEALTH SOURCE: PureTech Health plc Copyright Business Wire 2025. PUB: 07/08/2025 12:45 PM/DISC: 07/08/2025 12:46 PM
Business Wire
29 minutes ago
- Business Wire
PureTech Announces Board Change
BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces that Raju Kucherlapati, PhD, has stepped down from his role as a member and Chair of the Board of Directors. "Raju has been an integral part of PureTech's journey for almost two decades, and we are deeply grateful for his dedication and leadership,' said Bharatt Chowrira, PhD, JD, PureTech's Chief Executive Officer. 'On behalf of the board, I'd like to wish Raju all the best in his future endeavors.' PureTech has appointed Sharon Barber-Lui, PureTech's Audit Committee Chair, as Interim Chair of the Board of Directors. In collaboration with the Nominating Committee, Ms. Barber-Lui will lead the process to identify a new Chair of the Board of Directors and will engage with shareholders to gather input on the criteria and overall board evolution as part of the process. Robert Langer, ScD, PureTech's Co-founder and member of the board said, 'Raju is a unique individual, an amazing scientist, and a great friend and mentor to so many people in the biotech industry. It has been an honor and a privilege to serve alongside Raju for so many years at PureTech. I speak for the entire board in thanking him for his many years of dedication and his outstanding contributions.' During his tenure on the board, Dr. Kucherlapati helped guide PureTech from its startup phase into an established biotherapeutics company, which has an industry-leading track record of advancing breakthrough medicines, such as the recently FDA-approved Cobenfy™, and launching innovative Founded Entities, most recently, Seaport Therapeutics. About PureTech Health PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep portfolio through its experienced research and development team and its extensive network of scientists, clinicians, and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including three that have been approved by the U.S. Food and Drug Administration. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration-enabling studies. All of the underlying programs and platforms that resulted in this portfolio of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points. For more information, visit or connect with us on X (formerly Twitter) @puretechh. Cautionary Note Regarding Forward-Looking Statements This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements that relate to our expectations around our therapeutic candidates and approach towards addressing major diseases, our intention to initiate a process to identify a new Chair of the Board of Directors, our future prospects, developments, and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC and in our other regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, we disclaim any obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
Business Wire
38 minutes ago
- Business Wire
Algolia Named a Leader in 2025 Gartner ® Magic Quadrant
SAN FRANCISCO--(BUSINESS WIRE)-- Algolia, the AI-native search and discovery platform trusted by 18,000 businesses and millions of developers worldwide, today announced it has been named a Leader in the 202 5 Gartner® Magic Quadrant™ for Search and Product Discovery. Gartner noted 'Leaders demonstrate the ability to provide a depth and breadth of functionality. They deliver capabilities across multiple industries and business models that can scale up to support large search volumes. They provide sales and support services both directly and through an ecosystem of application, service and integration partners. They innovate, typically by means of technology updates, new products and product functionality, investments inside and outside core S&PD, and programs that improve customers' ability to succeed. Leaders tend to be mature in a market, and also have financial, technical and organizational viability, and consistently feature in Gartner clients' evaluations of vendors. They often set the competitive benchmark against which other vendors measure themselves.' Algolia leverages cutting-edge Retrieval Augmented Generation (RAG) and Large Language Models (LLMs) to understand the intent behind search queries and improve relevancy. By understanding both context and words, Algolia helps businesses across diverse verticals increase customer loyalty, reduce manual upkeep, and meet business goals. Bernadette Nixon, CEO of Algolia said: 'We believe this recognition by Gartner is a testament to our vision and passion for delivering value and results for our customers. The other thing we're excited about at the moment is the power of agentic AI powered by Algolia, where software powered by language models is no longer limited to answering questions, but can autonomously make decisions and take actions to support business goals.' Algolia's recently announced Model Context Protocol (MCP) Server is the first proof point in a long-term roadmap aimed at positioning Algolia as both the retrieval layer for agents and a trusted foundation for agent-oriented applications. AI-First Platform Built for Scale Algolia's API-first platform is cloud agnostic and runs on a multi-cloud infrastructure (AWS, Azure, GCP) and includes: AI Search – Real-time semantic and keyword search with context awareness AI Browse – Personalized category navigation powered by intent signals AI Recommendations – Behavior- and vector-based suggestions for discovery Merchandising Studio – Low-code tools for business users to guide AI behavior Analytics – Action-oriented insights like Next Best Actions for ongoing optimization With support for over 60 languages out of the box, Algolia enables rapid, multi-market rollout with no additional tuning required. Innovation Spotlight: Agentic AI & Generative AI In the past six months, Algolia launched several major AI-driven advancements: Context-Aware Retrieval for the Agentic era – A breakthrough in autonomous decisioning, enabling the search engine to act on user intent, adapt in real-time, and self-optimize — from auto-generating synonyms to launching new workflows Intelligent Fashion Solution – A bold, fashion-first innovation bringing AI-powered capabilities to every layer of the online retail experience Smart Groups – AI-powered curation and automation for content and merchandising teams AI-Ranking – Next generation ranking comprising Advanced Dynamic Reranking, Multi-Signal Ranking, and Dynamic Reranking for revenue Shopping Guides – A Generative AI tool for elevating the online shopping experience These innovations build on Algolia's mission to make AI-native Search and Discovery the most powerful lever in the modern digital experience stack — for both B2C and B2B brands. Platform Adoption and Ecosystem Algolia serves thousands of customers globally across retail, media, travel, SaaS, and financial services. It supports midmarket and enterprise clients with a robust partner ecosystem, developer tooling, and transparent pricing, including a free tier for developers managing up to 1 million SKUs. Gartner Magic Quadrant research methodology provides a graphical competitive positioning of four types of technology providers in fast-growing markets: Leaders, Visionaries, Niche Players and Challengers. Bernadette Nixon added: 'We consider Algolia's position as a Magic Quadrant Leader validates the strength of our AI architecture—from vector and hybrid search to agentic workflows and GenAI capabilities. We've built a platform engineered for speed, scale, and precision—because relevance at millisecond latency isn't optional. It's expected.' From Algolia's perspective, at the core of its positioning lies its unmatched data footprint, AI-first architecture, and proven impact across conversion, cross-sell, user engagement, ad performance, and order value applications. To learn why 18,000+ companies trust Algolia's industry-leading AI, experience Algolia AI Search first-hand here or request a demo. Source: Gartner, " Magic Quadrant for Search and Product Discovery," Mike Lowndes, Aditya Vasudevan, Sandy Shen, Noam Dorros, June 25, 2025. Gartner Disclaimer Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. About Algolia Algolia is a leading provider of AI search solutions, serving over 18,000 businesses and 500,000 developers globally. Renowned for its user-friendly API-First platform and the fastest AI search technology, Algolia is the largest hosted search engine, trusted by businesses and developers for 1.75 trillion searches per year. Backed by a decade of innovation, expertise, and growth, Algolia continuously redefines the search landscape with its commitment to user-friendly solutions, significant scalability, and unmatched speed. Learn more:
